HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ruo-Xu Gu Selected Research

(S)- (1- azabicyclo(2.2.2)oct- 3- yl)carbamic acid (S)-1-(2-fluorophenyl) ethyl ester

5/2010Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human alpha7 nicotinic acetylcholine receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Ruo-Xu Gu Research Topics

Disease

3Human Influenza (Influenza)
10/2013 - 07/2011
2Alzheimer Disease (Alzheimer's Disease)
02/2013 - 05/2009
1Infection
05/2013
1Dementia (Dementias)
05/2010
1Pain (Aches)
05/2010

Drug/Important Bio-Agent (IBA)

2Protons (Proton)IBA
10/2013 - 05/2013
2RimantadineFDA LinkGeneric
10/2013 - 05/2013
2Amantadine (Aman)FDA LinkGeneric
10/2013 - 05/2013
2alpha7 nicotinic acetylcholine receptorIBA
02/2013 - 05/2009
1AdamantaneIBA
07/2011
1(S)- (1- azabicyclo(2.2.2)oct- 3- yl)carbamic acid (S)-1-(2-fluorophenyl) ethyl esterIBA
05/2010
1Ion Channels (Ion Channel)IBA
05/2009